The problem with cancer-detecting dogs is that, well, they’re dogs. Hospitals haven’t embraced the idea of a diagnostic tool that poops, barks, and requires feeding. With such concerns in mind, technology startups have hustled to build digital devices that can mimic the dogs’ olfactory sense and reduce the need for biopsies and CAT scans. Metabolomx, a 12-person outfit in Mountain View, Calif., now appears on the fast track—insofar as such a thing exists in the heavily regulated medical field—to bringing a cancer-sniffing device to market.
Senior Scientist Dr. Nuria Queralto using the Metabolomx Breath Analysis Instrument. The machine requires patients to breathe in and out for four minutes.